top
Please input keywords
포스터 다운로드
CNS Drug Delivery Summit 2023: Discovery of RenNano-derived human heavy-chain-only TFR1 antibodies that can efficiently cross the blood-brain barrier and deliver drug payload
• hTFR1-targeting HCAbs developed from RenNano® mice have nM range affinity to human TFR1, and have functional capabilities, including internalization capacity. • hTFR1-targeting HCAbs are able to penetrate the BBB and deliver drug payload to the brain parenchyma efficiently. • Together, these data highlight the tremendous potential for HCAbs and its variable domain sdAbs for transporting cargo across the BBB. Due to their smaller size and simpler structure, sdAbs could ultimately provide therapeutic benefit for neurodegenerative diseases, and offer promising potential for tumor penetration.
*Name
*Email
*Telephone
*Company
*Country
한국
미국
일본
중국
영국
호주
프랑스
독일
이탈리아
싱가포르
인도
러시아
캐나다
스위스
기타 국가
*City